Found 11 matching trials
A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Diffuse Non-Hodgkin Lymphoma PHASE1 This is a single arm, open-label, non-randomized, dose-escalation, phase I ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1 PHASE2 This investigator-initiated, prospective, single-arm, open-label, single-ce...
Show More Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Learn More & Join Trial
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1 PHASE2 This investigator-initiated, prospective, single-arm, open-label, single-ce...
Show More Location
Multiple Locations
Learn More & Join Trial
CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma PHASE1 The primary objective of this study is to explore the safety and efficacy o...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Phase II Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma PHASE2 The study is a Phase II, single-arm, open-label, single-dose clinical trial...
Show More Location
Beijing Boren Hospital
Learn More & Join Trial
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies EARLY_PHASE1 This is a single arm, open-label, single center study to determine the safe...
Show More Location
Qilu Hospital of Shandong University
Learn More & Join Trial
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases EARLY_PHASE1 Exploratory clinical study of CNCT19 anti CD19 cell therapy in the treatmen...
Show More Location
The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
A Clinical Trial of CNCT19 Cells in the Treatment of CD19 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia PHASE1 This is a single arm, open-label, non-randomized, dose-escalation, phase I ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric) PHASE1 This is a multi-center, phase Ib/II trial to evaluate the safety and effica...
Show More Location
The Second Hospital of Anhui Medical University
Learn More & Join Trial
Clinical Trial of CNCT19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia PHASE2 The study is a Phase II, single-arm, open-label, single-dose clinical trial...
Show More Location
Beijing Boren Hospital
Learn More & Join Trial